Cannara Biotech Inc.
LOVFF
$0.9125
$0.00610.67%
OTC PK
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 18.14M | 16.86M | 14.29M | 14.63M | 14.23M |
| Total Other Revenue | -- | -40.50K | 51.20K | -- | -- |
| Total Revenue | 18.14M | 16.82M | 14.34M | 14.63M | 14.23M |
| Cost of Revenue | 10.82M | 9.19M | 9.24M | 11.57M | 8.24M |
| Gross Profit | 7.32M | 7.63M | 5.11M | 3.07M | 5.99M |
| SG&A Expenses | 3.99M | 3.70M | 3.56M | 4.13M | 3.06M |
| Depreciation & Amortization | 204.10K | 365.60K | 175.50K | 168.70K | 299.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.15M | 13.43M | 13.23M | 16.11M | 11.75M |
| Operating Income | 2.99M | 3.39M | 1.11M | -1.47M | 2.48M |
| Income Before Tax | 2.21M | 2.77M | 1.48M | -2.57M | 1.54M |
| Income Tax Expenses | 529.20K | -1.43M | -- | -- | -- |
| Earnings from Continuing Operations | 1.68M | 4.20M | 1.48M | -2.57M | 1.54M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.68M | 4.20M | 1.48M | -2.57M | 1.54M |
| EBIT | 2.99M | 3.39M | 1.11M | -1.47M | 2.48M |
| EBITDA | 4.07M | 4.63M | 2.17M | -437.40K | 3.62M |
| EPS Basic | 0.02 | 0.05 | 0.02 | -0.03 | 0.02 |
| Normalized Basic EPS | 0.02 | 0.02 | 0.00 | -0.02 | 0.01 |
| EPS Diluted | 0.02 | 0.04 | 0.01 | -0.03 | 0.01 |
| Normalized Diluted EPS | 0.02 | 0.02 | 0.00 | -0.02 | 0.01 |
| Average Basic Shares Outstanding | 90.02M | 90.02M | 90.02M | 90.02M | 90.22M |
| Average Diluted Shares Outstanding | 91.58M | 91.52M | 91.52M | 90.02M | 91.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |